For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Carisoprodol 700mg | tablet experimental formulation | None | None | 0 | 278 | 78 | 278 | View |
| Carisoprodol 500mg Tablet | tablet experimental formulation | None | None | 1 | 280 | 65 | 280 | View |
| Placebo Tablet | tablet placebo no experimental formulation | None | None | 0 | 275 | 37 | 275 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| transient ischemic attack | SYSTEMATIC_ASSESSMENT | Cardiac disorders | MeDRA | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| nausea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MeDRA | View |
| somnolence | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MeDRA | View |
| dizziness | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MeDRA | View |
| fatigue | NON_SYSTEMATIC_ASSESSMENT | General disorders | MeDRA | View |
| headache | NON_SYSTEMATIC_ASSESSMENT | General disorders | MeDRA | View |